Marker identifies breast cancer patients likely to respond to tamoxifen
Wednesday, May 18, 2011 - 09:30
in Health & Medicine
Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy.